GILEAD SCIENCES, INC. (GILD)
Clinical trial NCT06167317: enrollment: not set → 278 participants.
REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT05989126: enrollment: not set → 35 participants.
MINERVA NEUROSCIENCES, INC. (NERV)
Clinical trial NCT07565428: enrollment: not set → 380 participants.
BAYER A.G. (BAYZF)
Clinical trial NCT07282847 updates: 1. start date: 2026-02-10 → 2026-04-15 2. enrollment: not set → 12 participants
BRISTOL MYERS SQUIBB CO (BMY)
Clinical trial NCT07223047: enrollment: not set → 252 participants.
ASTRAZENECA PLC (AZN)
Clinical trial NCT07338942 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-30 → 2026-04-21 3. enrollment: not set → 4000 participants
MERCK & CO., INC. (MRK)
Clinical trial NCT07300280 updates: 1. status: ACTIVE_NOT_RECRUITING → RECRUITING 2. completion date: 2026-07-22 → 2026-10-14 3. primary completion date: 2026-07-15 → 2026-10-07 4. enrollment: not set → 60 participants
ASTRAZENECA PLC (AZN)
Clinical trial NCT07038928: enrollment: not set → 600 participants.
BOSTON SCIENTIFIC CORPORATION
Clinical trial NCT05973084: enrollment: not set → 1500 participants.
PFIZER INC (PFE)
Clinical trial NCT07575906 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. enrollment: not set → 8 participants